FCF is pleased to announce that Guy Levy has joined FCF’s Board of Directors. As our key leadership body, the Board of Directors helps assess and approve FCF’s research grants, and ensures that all important FCF decisions are in keeping with our mission and goals.

Guy’s background and experience should be invaluable to the Foundation. He has over 18 years of experience in financial services and deep expertise in many healthcare sub-verticals. Guy is the founder and Managing Partner of Soleus Capital Management, a Greenwich, Connecticut-based healthcare investment firm that is primarily focused on the life sciences, including biotech and medtech. Soleus Capital invests globally in developmental-stage through commercial-stage companies. Under Guy’s leadership, Soleus has been a lead investor in many healthcare companies including Galecto, Antios Therapeutics and Beta Bionics.

Prior to founding Soleus Capital, Guy worked as a partner, portfolio manager and investment analyst at several companies including Paulson & Co., Shumway Capital, Warburg Pincus and Morgan Stanley. Guy holds a B.A. from Yale University.

Click here to learn about the other members of FCF’s Board of Directors.